NURS 6521 Week 1 Assignment Case Study

Week 1 Assignment JJ, a little kid who will soon be 7 years old, has been battling asthma throughout his whole life. He has been hospitalized several times. There have been a number of different treatments that have been tried, and although some of them have been beneficial, none of them have been entirely effective. You are giving therapy for him, and you are aware of a research concerning the creation of a new drug for asthma. You are interested in seeing whether there is a connection between the two. This innovative treatment is administered through inhalation and contains bronchodilators, steroids, and antihistamines (Kliegman & St. Geme III, 2019). Nobody younger than 12 years old has ever been granted permission to use any of the medications that are now the subject of clinical studies. The study would take a total of one and a half months to complete. Before you enroll JJ in the research, you should first investigate his patient features and medical history so that you can devise a treatment plan that is tailored specifically to his needs. This includes JJ's present asthma symptoms, the work he is doing in treatment, as well as any other health issues that might potentially interfere with the success of the new medication (Ruiz et al., 2022). The members of the research team need to ascertain JJ's age as well as his degree of maturity before he can take part in the study. In the event that JJ is found to be a suitable participant for the research project, he will have to be continually examined in order to guarantee both his well-being and the efficient management of the asthma symptoms he is experiencing (Ruiz et al., 2022). This brand-new drug is still being evaluated, and according to the law, it cannot be provided to children who are less than 12 years old. It is imperative that this drug be used with the utmost care since there is a possibility that it might create severe adverse effects. In 3 the case that JJ's prescription is not covered by their health insurance, it is possible that JJ's parents will have to pay for it out of their own personal funds. Concerns of a moral and ethical nature surround the practice of administering prescription medication to minors. On the one hand, it is necessary to make sure that children get the asthma medication that they need, but on the other hand, it is essential to consider the hazards of using novel medicines that have not been investigated, especially in younger children. Consent given freely and knowingly is both an ethical and a legal matter (Kliegman & St. Geme III, 2019). Before a kid may be enrolled in a program, the child's parents or legal guardians are expected to have a comprehensive grasp of the program's possible hazards as well as its potential advantages. Before delivering treatment, medical professionals are required to go through a certain course of therapy. It is important for a medical professional to assess the possible downsides of that treatment against the potential benefits of that treatment. The ability to withdraw permission at any point throughout the process of gaining informed consent should be granted to the parents or guardians of the minors involved. If at all feasible, get the child's consent before doing so. In addition to this, the study team is responsible for maintaining the child's confidentiality and avoiding any unnecessary dangers. When it comes to dealing with disclosure and nondisclosure, one has a number of options available to them to choose from. Make it a point to inform JJ's parents about the possible advantages of taking part in the study as well as the potential risks involved in doing so. They should also be informed that the treatment that is being tried has not yet been licensed for use in children and may have hazards that are not yet understood by researchers. This information should be communicated to them. It is conceivable that after they have all of this information, they will make a decision about whether or not JJ should take part in a research study. In order